Bethany Pellegrino is a Nephrology physician affiliated with West Virginia University. OpenAlex indexes 24 publications with 482 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Stadium Drive
Morgantown, WV 26506
Telephone
304-598-4800Provider last certified this registry record 15 Apr 2022.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20251 payment
- Mallinckrodt Hospital Products Inc.Program year20241 payment
- Bayer Healthcare Pharmaceuticals Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
49.9%Loop diuretic12.3%Furosemide60%Bumetanide21%Torsemide19%Part D<11 patientsCalcium channel blocker11.8%Amlodipine Besylate75%Nifedipine Er25%Part D<11 patients+ 8 more classes in this area
Metabolism & gastrointestinal
23.8%Vitamin D3 Analog9%Calcitriol100%Part D≥16 patientsProton pump inhibitor7.1%Pantoprazole Sodium56%Omeprazole44%Part D<11 patients+ 3 more classes in this area
Other
11.7%Phosphate Binder8.1%Sevelamer Carbonate100%Part D≥13 patientsDrugs for treatment of hyperkalemia and hyperphosphatemia3.6%Velphoro54%Auryxia46%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Discontinuation of continuous kidney replacement therapy in patients with acute kidney injury: A pilot study
Journal of Critical Care
2026 - Fall Risk in Maintenance Hemodialysis Patients
Clinical Journal of the American Society of Nephrology
2025 - Correction to: Fall Risk in Maintenance Hemodialysis Patients: A Secondary Analysis of the HOPE Consortium Trial
Clinical Journal of the American Society of Nephrology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Peter Konrad, MD, PhD
West Virginia University
Hassan Ramadan, MD
West Virginia University
Ashkan Emadi, MD, PhD
West Virginia University
George Sokos, DO
West Virginia University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”